share_log

Mizuho Maintains Buy on Axsome Therapeutics, Lowers Price Target to $106

Mizuho Maintains Buy on Axsome Therapeutics, Lowers Price Target to $106

瑞穗维持对Axsome Therapeutics的买入,将目标股价下调至106美元
Benzinga ·  05/08 07:12

Mizuho analyst Graig Suvannavejh maintains Axsome Therapeutics (NASDAQ:AXSM) with a Buy and lowers the price target from $109 to $106.

瑞穗分析师格雷格·苏万纳维耶维持Axsome Therapeutics(纳斯达克股票代码:AXSM)的买入并将目标股价从109美元下调至106美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发